Skip to main content

Clearstead Advisors, LLC

Position in NVS — Novartis AG

CIK 842775 CLEVELAND, OH

Position in NVS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$3,955,456
-$1,349,246 QoQ
Shares Held
25,239
-27.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#306
of 1,602 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Clearstead Advisors, LLC holds $207,269,806 across 16 Drug Manufacturers - General names. NVS ranks #8 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVS
Novartis AG
This page
25,239 $3,955,456

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,955,456 25,239
2026-03-31 $5,304,702 34,728
2025-12-31 $2,637,453 19,130
2025-09-30 $2,438,868 19,018
2025-06-30 $2,304,514 19,044
2025-03-31 $2,108,755 18,916
2024-12-31 $1,851,128 19,023
2024-09-30 $2,260,258 19,651
2024-06-30 $2,305,923 21,660
2024-03-31 $2,069,828 21,398
2023-12-31 $2,160,556 21,398
2023-09-30 $2,332,186 22,896
2023-06-30 $2,308,215 22,874
2023-03-31 $2,096,128 22,784
2022-12-31 $2,066,964 22,784
2022-09-30 $1,830,624 24,084
2022-06-30 $2,063,715 24,414
2022-03-31 $2,142,328 24,414
2021-12-31 $2,135,492 24,414
2021-09-30 $2,021,438 24,718
2021-06-30 $2,293,591 25,138
2021-03-31 $2,410,450 28,199
2020-12-31 $2,655,654 28,123
2020-09-30 $2,437,054 28,025
2020-06-30 $2,507,007 28,704
2020-03-31 $1,504,217 18,244